C Font1,2,3, F Fernández-Avilés4, C Calderon5, T García-Fernández4, N Arab5,4, E Pineda4, E Buxó4, P Ayora4, M Carreño4, V Pereira5,4, M Viladot5,4, C Moreno4, C Gallego4, A Hernando4, N Creus4, C Barrera5,4, R Alcaraz4, J Sanchez4, A Prat5,4,6,7, A Tuca5,4. 1. Supportive and Palliative Care Unit (SPCU), Medical Oncology Department, Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain. CFONT@clinic.ub.es. 2. Institut Clinic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain. CFONT@clinic.ub.es. 3. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. CFONT@clinic.ub.es. 4. Institut Clinic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain. 5. Supportive and Palliative Care Unit (SPCU), Medical Oncology Department, Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain. 6. Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain. 7. Medical School, University of Barcelona, Barcelona, Spain.
Abstract
BACKGROUND: The development of reliable alternatives to conventional hospitalization in patients with cancer would have great clinical and economical value. The aim of the present study was to assess the feasibility of a home-based nursing intervention model as a safe alternative for the management of acute medical complications in cancer patients who would otherwise require conventional hospitalization. PATIENTS AND METHODS: From October 2013 to October 2014, we prospectively evaluated the outcomes of consecutive acute medical episodes treated at home under the home-based intervention program named the Bridge Project (BP). Episodes were classified as "avoided hospitalization in outpatients" (AHO) vs. "reduced hospitalization in inpatients" (RHI). The primary end-point was to assess the rate and causes of BP intervention failure (unplanned hospital readmission or death). RESULTS: Two hundred and forty-six consecutive episodes (52 % AHO and 48 % RHI) involving 203 patients (55 % male; mean age 63 years) were enrolled. The main conditions managed at home were non-neutropenic infections (40 %), febrile neutropenia (20 %), and cancer-related complications (28 %). The median duration of the BP intervention was 5 days (range 1-16 days). No deaths were reported at home. Unplanned hospital readmissions occurred in 9 % of episodes (14 % in AHO vs. 4 % in RHI; p = 0.001). Five of the 22 readmitted patients (22.7 % of the BP failures; 2.5 % of the whole series) died during hospitalization. The BP intervention burden was 1353 days, representing a potential saving of 14 % of days of hospitalization during the study period. CONCLUSIONS: The BP is a safe intervention which can potentially avoid or reduce the length of hospitalization in selected cancer patients with acute medical complications. Our findings support further development of innovative home-based clinical approaches to promote potentially avoidable hospitalization in this setting.
BACKGROUND: The development of reliable alternatives to conventional hospitalization in patients with cancer would have great clinical and economical value. The aim of the present study was to assess the feasibility of a home-based nursing intervention model as a safe alternative for the management of acute medical complications in cancer patients who would otherwise require conventional hospitalization. PATIENTS AND METHODS: From October 2013 to October 2014, we prospectively evaluated the outcomes of consecutive acute medical episodes treated at home under the home-based intervention program named the Bridge Project (BP). Episodes were classified as "avoided hospitalization in outpatients" (AHO) vs. "reduced hospitalization in inpatients" (RHI). The primary end-point was to assess the rate and causes of BP intervention failure (unplanned hospital readmission or death). RESULTS: Two hundred and forty-six consecutive episodes (52 % AHO and 48 % RHI) involving 203 patients (55 % male; mean age 63 years) were enrolled. The main conditions managed at home were non-neutropenic infections (40 %), febrile neutropenia (20 %), and cancer-related complications (28 %). The median duration of the BP intervention was 5 days (range 1-16 days). No deaths were reported at home. Unplanned hospital readmissions occurred in 9 % of episodes (14 % in AHO vs. 4 % in RHI; p = 0.001). Five of the 22 readmitted patients (22.7 % of the BP failures; 2.5 % of the whole series) died during hospitalization. The BP intervention burden was 1353 days, representing a potential saving of 14 % of days of hospitalization during the study period. CONCLUSIONS: The BP is a safe intervention which can potentially avoid or reduce the length of hospitalization in selected cancer patients with acute medical complications. Our findings support further development of innovative home-based clinical approaches to promote potentially avoidable hospitalization in this setting.
Entities:
Keywords:
Alternatives to conventional hospitalization; Home health care, patient-centered care; Home hospitalization in cancer; New models of cancer care
Authors: L Decoster; K Van Puyvelde; S Mohile; U Wedding; U Basso; G Colloca; S Rostoft; J Overcash; H Wildiers; C Steer; G Kimmick; R Kanesvaran; A Luciani; C Terret; A Hurria; C Kenis; R Audisio; M Extermann Journal: Ann Oncol Date: 2014-06-16 Impact factor: 32.976
Authors: Michael J Hassett; Sowmya R Rao; Suzana Brozovic; James E Stahl; Joel H Schwartz; Betty Maloney; Joseph O Jacobson Journal: Oncologist Date: 2011-02-24
Authors: Heather McKenzie; Lillian Hayes; Kathryn White; Keith Cox; Judith Fethney; Maureen Boughton; Jo Dunn Journal: Support Care Cancer Date: 2010-05-25 Impact factor: 3.603
Authors: Tim Cooksley; Carme Font; Florian Scotte; Carmen Escalante; Leslie Johnson; Ronald Anderson; Bernardo Rapoport Journal: Support Care Cancer Date: 2020-11-23 Impact factor: 3.603
Authors: Ignacio Gómez-Centurión; Gillen Oarbeascoa; María Carmen García; María Carmen López Fresneña; María Josefa Martínez Carreño; Vicente Escudero Vilaplana; Eva González-Haba; Rebeca Bailén; Nieves Dorado; Luis Miguel Juárez; Gabriela Rodríguez Macías; Patricia Font López; Cristina Encinas; Mariana Bastos-Oreiro; Javier Anguita; María Sanjurjo; José Luis Díez-Martin; Mi Kwon Journal: Int J Hematol Date: 2021-09-22 Impact factor: 2.490